These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2562478)

  • 1. Conversion of ABO blood groups.
    Goldstein J
    Transfus Med Rev; 1989 Jul; 3(3):206-12. PubMed ID: 2562478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning, sequence, and expression of a blood group B active recombinant alpha-D-galactosidase from pinto bean (Phaseolus vulgaris).
    Davis MO; Hata DJ; Johnson SA; Jones DE; Harmata MA; Evans ML; Walker JC; Smith DS
    Biochem Mol Biol Int; 1997 Jul; 42(3):453-67. PubMed ID: 9247703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for the presence of A antigen on group B erythrocytes through the use of specific exoglycosidases.
    Goldstein J; Lenny L; Davies D; Voak D
    Vox Sang; 1989; 57(2):142-6. PubMed ID: 2551097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-gal A/B, a novel anti-blood group antibody identified in recipients of abo-incompatible kidney allografts.
    Galili U; Ishida H; Tanabe K; Toma H
    Transplantation; 2002 Dec; 74(11):1574-80. PubMed ID: 12490791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer.
    Hakomori S
    Biochim Biophys Acta; 1999 Dec; 1473(1):247-66. PubMed ID: 10580143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B to O erythrocyte conversion by the recombinant alpha-galactosidase.
    Zhang YP; Gong F; Bao GQ; Gao HW; Ji SP; Tan YX; Li SB; Li LL; Wang YL; Xu H; Xu LJ; Tian SG; Zhang ZX; Lü QS; Qiu Y; Bai JS; Chen JT
    Chin Med J (Engl); 2007 Jul; 120(13):1145-50. PubMed ID: 17637242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deantigenation of human type B erythrocytes with Glycine max alpha-D-galactosidase.
    Hobbs L; Mitra M; Phillips R; Haibach H; Smith D
    Biomed Pharmacother; 1995; 49(5):244-50. PubMed ID: 7579003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O.
    Lenny LL; Hurst R; Goldstein J; Galbraith RA
    Transfusion; 1994 Mar; 34(3):209-14. PubMed ID: 8146892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designer red cells.
    Wilson RB; Spitalnik SL
    Transfusion; 1994 Mar; 34(3):189-91. PubMed ID: 8146889
    [No Abstract]   [Full Text] [Related]  

  • 11. Akkermansia muciniphila exoglycosidases target extended blood group antigens to generate ABO-universal blood.
    Jensen M; Stenfelt L; Ricci Hagman J; Pichler MJ; Weikum J; Nielsen TS; Hult A; Morth JP; Olsson ML; Abou Hachem M
    Nat Microbiol; 2024 May; 9(5):1176-1188. PubMed ID: 38684911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human blood group glycosphingolipids of porcine erythrocytes.
    Sako F; Gasa S; Makita A; Hayashi A; Nozawa S
    Arch Biochem Biophys; 1990 Apr; 278(1):228-37. PubMed ID: 1690965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human blood group scFv antibodies derived from a V gene phage-display library.
    Hughes-Jones NC; Gorick BD; Bye JM; Finnern R; Scott ML; Voak D; Marks JD; Ouwehand WH
    Br J Haematol; 1994 Sep; 88(1):180-6. PubMed ID: 7803241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of recombinant alpha-galactosidase for use in seroconversion from blood group B to O of human erythrocytes.
    Zhu A; Leng L; Monahan C; Zhang Z; Hurst R; Lenny L; Goldstein J
    Arch Biochem Biophys; 1996 Mar; 327(2):324-9. PubMed ID: 8619622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-unit transfusions of RBC enzymatically converted from group B to group O to A and O normal volunteers.
    Lenny LL; Hurst R; Goldstein J; Benjamin LJ; Jones RL
    Blood; 1991 Mar; 77(6):1383-8. PubMed ID: 1848117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current experience with renal transplantation across the ABO barrier.
    Nelson PW; Helling TS; Shield CF; Beck M; Bryan CF
    Am J Surg; 1992 Nov; 164(5):541-4; discussion 544-5. PubMed ID: 1443385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of red blood cells to group O.
    Fricker J
    Lancet; 1996 Mar; 347(9002):680. PubMed ID: 8596389
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen.
    Hirohashi S; Clausen H; Yamada T; Shimosato Y; Hakomori S
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7039-43. PubMed ID: 2413456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new series of blood group A and H antigens expressed in human erythrocytes and the incompatible A antigens expressed in tumours of blood group O and B individuals.
    Hakomori SI; Clausen H; Levery SB
    Biochem Soc Trans; 1987 Aug; 15(4):593-6. PubMed ID: 3678582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.